Adhesion molecules in patients with chronic haemodialysis;Cza̧steczki adhezyjne u chorych hemodializowanych przewlekle

Polski Merkuriusz Lekarski

Volumn 13, Issue 75, 2002, Pages 177-181

  Musiał, Kinga ^a   Zwolińska, Danuta ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Biocompatibility; Cell adhesion molecules; Hemodialysis

Indexed keywords

CELL ADHESION MOLECULE; BIOMATERIAL;

ARTIFICIAL KIDNEY; BIOCOMPATIBILITY; DIALYSIS MEMBRANE; HEMODIALYSIS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; MEMBRANE BINDING; MOLECULAR INTERACTION; REVIEW; RISK ASSESSMENT; ARTIFICIAL MEMBRANE; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; DEGRANULATION; DRUG EFFECT; EDITORIAL; IMMUNOLOGY; INSTRUMENTATION; LEUKOCYTE COUNT; METABOLISM; METHODOLOGY; NEUTROPENIA; NEUTROPHIL; RENAL REPLACEMENT THERAPY;

BIOCOMPATIBLE MATERIALS; CELL ADHESION MOLECULES; CELL DEGRANULATION; HUMANS; KIDNEY FAILURE, CHRONIC; LEUKOCYTE COUNT; MEMBRANES, ARTIFICIAL; NEUTROPENIA; NEUTROPHILS; RENAL DIALYSIS;

EID: 0036385997     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Alvarez V. i wsp.: Differentially regulated cell surface expression of leukocyte adhesion receptors on neutrophils. Kidney Int., 1991, 40, 899-905.
2. Bonomini M. i wsp.: Serum Levels of Soluble Adhesion Molecules in Chronic Renal Failure and Dialysis Patients. Nephron, 1998, 79, 399-407.
3. Bonomini M. i wsp.: Neutrophil reactive oxygen species production during hemodialysis: role of activated platelet adhesion to neutrophils through P-selectin. Nephron, 1997, 75, 402-411.
4. Bonventre J.V., Colvin R.B.: Adhesion molecules in renal disease. Curr. Opin. Nephrol. Hypert., 1996, 5, 254-61.
5. Burkhardt K. i wsp.: The significance of adhesion molecules in nephrology. Artif. Org., 1996, 20, 433-436.
6. Canton A.D.: Adhesion molecules in renal disease. Kidney Int., 1995, 48, 1687-1696.
7. Carlos T.M., Harlan J.M.: Leukocyte-endothelial adhesion molecules. Biood, 1994, 84, 2068-2101.
8. Carreno M.P. i wsp.: Cell-associated adhesion molecules as early markers of bioincompatibility, Nephrol. Dial. Transplant., 1996, 11, 2248-2257.
9. Cheung A.K. i wsp.: Adhesion molecules and artificial membranes. in: Adhesion molecules in health and disease (ed. Paul L.C., Issekutz T.B.). Marcel Dekker. New York. 1997, 643-678.
10. Combe C. i wsp.: Granulocyte activation and adhesion molecules during hemodialysis with cuprophane and a high-flux biocompatible membrane. Am. J. Kidney Dis., 1994, 24, 437-442.
11. Descamps-Latscha B.: The immune system in end-stage renal disease. Curr. Opin. Nephrol. Hypert., 1993, 2, 883-891.
12. Dou L. i wsp.: Effect of uremia and hemodialysis on soluble I-selectin and leukocyte surface CD11b and L-selectin. Am. J. Kidney Dis., 1998, 31, 67-73.
13. Gearing A.J.H., Newman W.: Circulating adhesion molecules in disease. Immunol. Today, 1993, 14, 506-512.
14. Hakim R.M. i wsp.: Biocompatibility of dialysis membranes, Effects of chronic complement activation. Kidney Int., 1984, 26, 194-200.
15. Himmelfarb J. i wsp.: Modulation of granulocyte LAM-1 and MAC-1 during dialysis - A prospective, randomized trial. Kidney Int., 1992, 41, 388-395.
16. Kawabata K. i wsp.: The changes of Mac-1 and L-selectin expression on granulocytes and soluble L-selectin level during hemodialysis. Nephron, 1996, 73, 573-579.
17. Mailloux L.U.: Hypertension in chronic renal failure and ESRD, prevalence, pathophysiology, and outcomes. Semin. Nephrol., 2001, 21, 146-156.
18. Mrowka C. i wsp.: Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis? Clin. Nephrol., 1999, 52: 312-321.
19. Nagata K. i wsp.: Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62). J. Immunol., 1993, 151, 6, 3267-3273.
20. Noris M., Remuzzi G.: New insights into circulating cell-endothelium interactions and their significance for glomerular pathophysiology. Am. J. Kidney Dis. 1995, 26, 541-548.
21. Omata M. i wsp.: Reduction of neutrophil activation by vitamin E modified dialyzer membranes. Nephron, 2000, 85, 221-231.
22. Petruzzelli L., Takami M., Humes H.D.: Structure and function of cell adhesion molecules. Am. J. Med., 1999, 106, 467-476.
23. Rabb H. i wsp.: Alterations in sICAM-1 and sVCAM-1 in hemodialysis patients. Am. J. Kidney Dis., 1996, 27, 239-243.
24. Stuard S. i wsp.: A major role for CD62P/CD15s interaction in leukocyte margination during hemodialysis. Kidney Int., 1995, 48, 93-102.
25. Thylen P. i wsp.: Monocyte and granulocyte CD11b/CD18, CD62L expression and sICAM-1 concentration in the interdialytic period. Nephron, 1996, 74, 275-282.
26. Tielemans C.L. i wsp.: Adhesion molecules and leukocyte common antigen on monocytes and granulocytes during hemodialysis. Clin. Nephrol., 1993, 39, 158-165.
27. Vanholder R. i wsp.: Phagocytosis in uremic and hemodialysis patients. A prospective and cross sectional study. Kidney Int., 1991, 39, 320-327.
28. Zachee P. i wsp.: Neutrophil adhesion molecules in chronic hemodialysis patients. Nephron, 1994, 68, 192-196.